A year into the COVID-19 pandemic, Johnson & Johnson leads sales growth in the US OTC pain relief space with Tylenol and in the allergy category with Zyrtec, according to market research firm Information Resources Inc.
Tylenol Leads OTC Acetaminophen Sales Surge After Ibuprofen Scare During Pandemic – IRI
J&J leads sales growth in OTC pain relief and allergy categories in 2020 as its brands benefited from competing products’ problems and COVID-19’s impact of consumer habits. IRI reveals winning brands that kept a focus on maintaining health in 2020.
